for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reckitt Benckiser Group Plc

RB.L

Latest Trade

7,544.00GBp

Change

-74.00(-0.97%)

Volume

205,352

Today's Range

7,524.00

 - 

7,656.00

52 Week Range

5,130.00

 - 

8,020.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
7,618.00
Open
7,620.00
Volume
205,352
3M AVG Volume
17.16
Today's High
7,656.00
Today's Low
7,524.00
52 Week High
8,020.00
52 Week Low
5,130.00
Shares Out (MIL)
711.37
Market Cap (MIL)
53,139.29
Forward P/E
23.48
Dividend (Yield %)
2.34

Next Event

Q3 2020 Reckitt Benckiser Group PLC Interim Management Statement Release

Latest Developments

More

Reckitt Benckiser H1 Adj EPS From Cont Ops 166.5 Pence

Reckitt Benckiser Appoints Sami Naffakh As Chief Supply Officer

Reckitt Benckiser Announces Pricing Of Multi-Tranche Senior Notes Offering

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Reckitt Benckiser Group Plc

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Vanish and Woolite.

Industry

Personal & Household Prods.

Contact Info

103-105 Bath Road

SL1 3UH

United Kingdom

+44.1753.217800

https://www.rb.com

Executive Leadership

Christopher Alan Sinclair

Non-Executive Chairman of the Board

Laxman Narasimhan

Chief Executive Officer, Director

Jeffrey Carr

Chief Financial Officer, Executive Director

Kris Licht

President - Health, Global Chief Customer Officer

Aditya Sehgal

President - Nutrition, President China and E-RB

Key Stats

2.19 mean rating - 21 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2017

11.5K

2018

12.6K

2019

12.8K

2020(E)

13.8K
EPS (GBp)

2017

324.600

2018

339.900

2019

349.000

2020(E)

318.565
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.93
Price To Book (MRQ)
5.33
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
128.42
LT Debt To Equity (MRQ)
112.26
Return on Investment (TTM)
-9.65
Return on Equity (TTM)
-7.46

Latest News

Latest News

Exclusive: Reckitt kicks off sale of some personal care brands - sources

Consumer goods group Reckitt Benckiser Group <RB.L> is preparing to sell some of its non-core personal care brands, including Veet hair removal cream and Clearasil acne cream, four sources familiar with the matter said on Monday.

Delta teams up with Lysol to innovate on travel hygiene

Delta Air Lines <DAL.N> said on Monday it is teaming up with Reckitt Benckiser Group Plc <RB.L>, the makers of Lysol, to research and develop new disinfecting solutions for high-traffic areas in airports and onboard, with a first focus on airplane lavatories.

Brazilian waste management firm finds cost-cutting users in pandemic

A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser <RB.L> and Siemens AG <SIEGn.DE>, and logistics firm Luft, its chief executive said on Thursday...

U.S. EPA approves use of Lysol Disinfectant Spray against COVID-19

UK-based Reckitt Benckiser Group Plc <RB.L> said on Tuesday that the U.S. Environmental Protection Agency (EPA) has approved use of its Lysol Disinfectant Spray against COVID-19.

Reckitt Benckiser's sales surge on coronavirus disinfectant boom

Reckitt Benckiser <RB.L> achieved record sales growth in the first quarter and predicted a stronger than expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap ahead of the coronavirus lockdowns.

London stocks rise on optimism around virus drug, upbeat earnings

UK stock markets rose on Thursday as investors cheered signs of progress in developing a treatment for the novel coronavirus, while Reckitt Benckiser surged after reporting strong demand for its products ahead of the lockdown.

BRIEF-Reckitt Benckiser Posts Record Sales On Disinfectant Boom

* RECKITT - QTRLY REVENUE 3,544 MILLION STG VERSUS 3,157 MILLION STG AS REPORTED A YEAR EARLIER

BRIEF-Reckitt Benckiser Says Co's Disinfectant Products Should Not Be Administered Into Human Body Through Injection, Ingestion, Any Other Route

* RECKITT BENCKISER- CO'S DISINFECTANT PRODUCTS SHOULD NOT BE ADMINISTERED INTO HUMAN BODY THROUGH INJECTION, INGESTION, ANY OTHER ROUTE Source text: https://bit.ly/3cHBvkY Further company coverage:

BRIEF-Reckitt Looks To Up Capacity Of Disinfectants, Sanitisers, Soaps In 2020

* RECKITT BENCKISER - ANNOUNCING LAUNCH OF THE RB FIGHT FOR ACCESS FUND TO IMPROVE ACCESS TO HEALTH, HYGIENE AND NUTRITION FOR ALL

BRIEF-Reckitt Says Not Aware Of Evidence Ibuprofen Impacts Covid-19 Patients

* RECKITT -AWARE OF SOCIAL MEDIA IN FRANCE CONCERNS ON USE OF STEROIDS & NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS FOR ALLEVIATION OF COVID-19 SYMPTOMS

UPDATE 3-Reckitt takes short term pain for long term growth

* Shares rebound after almost 5% fall (Adds analysts comments, breakingviews link)

Reckitt Benckiser sales come in low, unveils 2 bln investment plan

British household goods maker Reckitt Benckiser reported full-year comparable sales at the low end of company forecasts on Thursday, as it suffered from a slowdown in demand for over-the counter medicines in the United States and infant formula in China, its biggest market.

UPDATE 1-Reckitt's HyHo resurgence buys time for new CEO Narasimhan

A reversal of fortune at two of its businesses has bought new Reckitt Benckiser chief executive Laxman Narasimhan some time after pressure for a break-up of the household goods maker.

Reckitt's HyHo resurgence buys time for new CEO Narasimhan

A reversal of fortune at two of its businesses has bought new Reckitt Benckiser chief executive Laxman Narasimhan some time after pressure for a break-up of the household goods maker.

Factbox - Surging sterling's impact on European consumer companies

European consumer companies Reckitt Benckiser <RB.L> and Tate & Lyle <TATE.L> could take an earnings hit of as much as 2.5% from the sterling's surge on British Prime Minister Boris Johnson's resounding election victory on Friday.

Britain's Reckitt Benckiser gives new parents more paid leave

British household goods maker Reckitt Benckiser Group Plc <RB.L> said on Tuesday it was extending its paid leave globally for new mothers from 16 weeks to 26 weeks, but the change will take time to implement in the United States due to regulatory issues.

In fee fight with generics, Reckitt gets off with warning from judge

The federal judge who rejected Mucinex-maker Reckitt Benckiser’s patent-infringement claims against Amneal Pharmaceuticals and Dr. Reddy’s Laboratories denied the generic drug makers’ motion for attorneys’ fees on Friday, but strongly cautioned Reckitt against filing similar...

New York, states reach $700 million settlement with Reckitt over opioid probes

New York and other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday.

New York, states reach $700 mln settlement with Reckitt over opioid probes

New York and five other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday.

New CEO vows improvements as Reckitt cuts sales forecast again

Reckitt Benckiser's <RB.L> new chief executive promised on Tuesday to step up spending on its brands and improve performance after the British household goods maker cut its full-year sales forecast for a second time.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up